Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and toxicity of the weekly combination chemotherapy of Paclitaxel,
Carboplatin and Irinotecan in Stage IIIb and IV NSCLC with malignant pleural effusion
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins